MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tipsro.2024.100272

Медицинская библиотека · Technical innovations & patient support in radiation oncology · 2024

Global assessment of swallow function (GASF) following VMAT radiotherapy for head and neck squamous cell carcinoma.

Toft Kate, McLachlan Kirsty, Winton Mark, Mactier Karen, Hare Nadine, Nugent Claire, Wincott Lucie, Srinivasan Devraj, Mackenzie Joanna, Nailon Bill, Noble David

СтатьяПеревод в очереди

Аннотация

AIM: This study aimed to conduct a global assessment of swallow function (GASF) using a range of swallow outcome tools, in a cohort of patients pre- and post-treatment with image-guided volumetric modulated arc therapy (VMAT) radiotherapy.

MATERIALS AND

METHODS

All patients receiving radical (chemo)radiation for SCC of the larynx, oro-, hypo- or nasopharynx between October 2016 - 2021 were eligible for inclusion.Patients were treated with VMAT radiotherapy according to institutional and national protocols.Patients underwent GASF pre- and 6 months post-treatment. Data were collated from the MD Anderson Dysphagia Inventory (MDADI), the Functional Oral Intake Scale (FOIS), the Performance Status Scale-Head and Neck: Normalcy of Diet scale (PSS-NoD), the 100 ml water swallow test (WST) for capacity and maximal interincisal opening (MIO).

RESULTS

One hundred and seventy-five patients were included. 55.2 % of patients experienced a fall in MDADI-Composite score greater than the published meaningful clinical important difference (MCID).A trend for a decrease in FOIS score reflects a decrease in range of diet textures and increase in reliance on enteral feeding at 6 months post-treatment.Mean PSS-NoD score decreased reflecting increased restriction in diet textures.20 patients' WST capacity improved by the minimal clinically important difference of > 4mls whilst 37 % of patients experienced a decrease in WST capacity of 4mls or more. 12.6 % of patients developed trismus following radiotherapy.

CONCLUSIONS

This paper adds new detail to the understanding of the decline in measured eating, drinking and swallowing function that patients treated with VMAT radiotherapyexperience at 6 months post treatment. However, gaps are highlighted in the evidence base in terms of interpretation of swallow outcomes tool scores; future research in HNC should include ongoing discussion and development around robust outcomes tools and data collection.

Для цитирования: Toft Kate, McLachlan Kirsty, Winton Mark, Mactier Karen, Hare Nadine, Nugent Claire, Wincott Lucie, Srinivasan Devraj, Mackenzie Joanna, Nailon Bill, Noble David. Global assessment of swallow function (GASF) following VMAT radiotherapy for head and neck squamous cell carcinoma.. Technical innovations & patient support in radiation oncology. 2024. DOI: 10.1016/j.tipsro.2024.100272.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.